Table 2.
Time after vaccination | No. detected | No. positive | Positive rate (%) | GMC* (95%CI) |
---|---|---|---|---|
20 | 42 | 30 | 71.43 | 138.04 (77.63 ~ 251.18) |
21 | 73 | 47 | 64.38 | 213.80 (138.04 ~ 338.84) |
22 | 47 | 32 | 68.08 | 190.55 (104.71 ~ 346.74) |
23 | 55 | 32 | 58.18 | 117.49 (66.07 ~ 213.80) |
24 | 34 | 17 | 50.00 | 69.18 (28.84 ~ 162.18) |
25 | 55 | 29 | 52.73 | 117.49 (66.07 ~ 204.17) |
26 | 64 | 35 | 54.69 | 89.13 (56.23 ~ 158.49) |
27 | 80 | 44 | 55.00 | 128.83 (79.43 ~ 208.93) |
28 | 96 | 46 | 47.92 | 107.15 (74.13 ~ 154.88) |
29 | 147 | 61 | 41.50 | 100.00 (69.18 ~ 141.25) |
30 | 164 | 79 | 48.17 | 95.50 (69.18 ~ 141.25) |
31 | 36 | 16 | 44.44 | 109.65 (52.48 ~ 223.87) |
total | 893 | 468 | 52.41 | 112.20 (97.72 ~ 128.82) |
*GMC of the anti-HBs-positive participants